CRISPR Therapeutics shares early autoimmune and lymphoma data for zugo-cel, showing strong responses, manageable safety, and ...

According to Benzinga Pro, CRISPR Therapeutics AG's peer group average for short interest as a percentage of float is 14.28%, ...

Large-scale human genetics studies have shown that many risk variants for common and complex diseases sit in the non-coding ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Check out our updated preview for tonight's midseason finale of CBS's Morris Chestnut-starring Watson, S02E10: "Never Been ...

DelveInsight's Gene Therapies for Cardiomyopathies Market Insights report includes a comprehensive understanding of current treatment practices, emerging gene therapies for cardiomyopathies, market ...

Robert Carlyle's Sherlock Holmes returns and more in sneak peeks at CBS's Morris Chestnut-starring Watson S02E10: "Never Been ...

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

The pace of innovation in the Life Sciences field is accelerating, and the regulatory oversight of the resulting products and ...

The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Plant Breeding and CRISPR Plants was valued at US$21 ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...